by fctdiadmin | Jun 5, 2023 | Uncategorized
Fox Chase Therapeutics Discovery Inc (formerly known as Fox Chase Chemical Diversity Center) Announces That a New Drug Application Was Submitted to the FDA for Troriluzole by Biohaven Pharmaceuticals Doylestown, PA. June 5, 2023 – Fox Chase Therapeutics...
